Study Evaluating the Effects of Avanafil on Semen Parameters
Public ClinicalTrials.gov record NCT01768676. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Clinical Trial of the Effect of Avanafil (STENDRA™) on Spermatogenesis in Healthy Adult Males and Adult Males With Mild Erectile Dysfunction
Study identification
- NCT ID
- NCT01768676
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- VIVUS LLC
- Industry
- Enrollment
- 181 participants
Conditions and interventions
Conditions
Interventions
- avanafil Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- Male
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2012
- Primary completion
- Jul 31, 2014
- Completion
- Jul 31, 2014
- Last update posted
- Dec 13, 2015
2012 – 2014
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Facility | Huntsville | Alabama | — | — |
| Research Facility | Los Angeles | California | — | — |
| Research Facility | San Diego | California | — | — |
| Research Facility | Parker | Colorado | — | — |
| Research Facility | Aventura | Florida | — | — |
| Research Facility | Carmel | Indiana | — | — |
| Research Facility | New Orleans | Louisiana | — | — |
| Research Facility | Shreveport | Louisiana | — | — |
| Research Facility | Kansas City | Missouri | — | — |
| Research Facility | Albany | New York | — | — |
| Research Facility | New York | New York | — | — |
| Research Facility | Cincinnati | Ohio | — | — |
| Research Facility | Bala-Cynwyd | Pennsylvania | — | — |
| Research Facility | Knoxville | Tennessee | — | — |
| Research Facility | San Antonio | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01768676, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 13, 2015 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01768676 live on ClinicalTrials.gov.